Xianqiong C. Gong

Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Dual-substrate SERS strategy combined with 3D AgNPs substrate for minimally invasive screening and staging of liver cancer.

Dual-substrate SERS strategy combined with 3D AgNPs substrate for minimally invasive screening and staging of liver cancer.

Journal: Analytica chimica acta

Published: May 10, 2026

Tanshinone IIA alleviates ferroptosis and oxidative injury in chronic experimental colitis through Nrf2 activation.

Tanshinone IIA alleviates ferroptosis and oxidative injury in chronic experimental colitis through Nrf2 activation.

Journal: Biochemical and biophysical research communications

Published: December 11, 2025

Label-free serum SERS combined with RFE-GBDT algorithm for non-invasive screening of liver cancer.

Label-free serum SERS combined with RFE-GBDT algorithm for non-invasive screening of liver cancer.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: November 03, 2025

A novel 3D flexible porous SERS platform for direct plasma-free amino acid profiling and multi-cancer screening.

A novel 3D flexible porous SERS platform for direct plasma-free amino acid profiling and multi-cancer screening.

Journal: Biosensors & bioelectronics

Published: April 05, 2025

Detection of hyaluronidase in urine using hyaluronic acid-coated silver nanoparticles-based surface-enhanced Raman spectroscopy for the diagnosis of bladder cancer.

Detection of hyaluronidase in urine using hyaluronic acid-coated silver nanoparticles-based surface-enhanced Raman spectroscopy for the diagnosis of bladder cancer.

Journal: Talanta

Published: March 06, 2025

Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Colitis-Associated Cancer in Mice by Regulating PTEN and ATPase Inhibitory Factor 1.

Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Colitis-Associated Cancer in Mice by Regulating PTEN and ATPase Inhibitory Factor 1.

Journal: Current pharmaceutical design

Published: February 21, 2025

Kan-AAE-driven synthetic SERS spectra generation method for Precise cancer identification.

Kan-AAE-driven synthetic SERS spectra generation method for Precise cancer identification.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: October 13, 2024

Impacts of small-molecule STAT3 inhibitor SC-43 on toxicity, global proteomics and metabolomics of HepG2 cells.

Impacts of small-molecule STAT3 inhibitor SC-43 on toxicity, global proteomics and metabolomics of HepG2 cells.

Journal: Journal of pharmaceutical and biomedical analysis

Published: December 04, 2023

Deletion of GPR81 activates CREB/Smad7 pathway and alleviates liver fibrosis in mice.

Deletion of GPR81 activates CREB/Smad7 pathway and alleviates liver fibrosis in mice.

Journal: Molecular medicine (Cambridge, Mass.)

Published: November 17, 2023

Negative regulation of pro-apoptotic AMPK/JNK pathway by itaconate in mice with fulminant liver injury.

Negative regulation of pro-apoptotic AMPK/JNK pathway by itaconate in mice with fulminant liver injury.

Journal: Cell death & disease

Published: September 29, 2022

Immune response gene 1 deficiency aggravates high fat diet-induced nonalcoholic fatty liver disease via promotion of redox-sensitive AKT suppression.

Immune response gene 1 deficiency aggravates high fat diet-induced nonalcoholic fatty liver disease via promotion of redox-sensitive AKT suppression.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: July 14, 2022

Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice.

Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice.

Journal: Biochemical and biophysical research communications

Published: March 15, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026